KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Current Deferred Revenue: 2018-2024

Historic Current Deferred Revenue for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to $82.9 million.

  • Adaptive Biotechnologies' Current Deferred Revenue fell 49.73% to $42.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.5 million, marking a year-over-year decrease of 49.73%. This contributed to the annual value of $82.9 million for FY2024, which is 11.22% down from last year.
  • Per Adaptive Biotechnologies' latest filing, its Current Deferred Revenue stood at $82.9 million for FY2024, which was down 11.22% from $93.4 million recorded in FY2023.
  • Over the past 5 years, Adaptive Biotechnologies' Current Deferred Revenue peaked at $179.2 million during FY2021, and registered a low of $73.3 million during FY2020.
  • In the last 3 years, Adaptive Biotechnologies' Current Deferred Revenue had a median value of $93.4 million in 2023 and averaged $99.7 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first spiked by 144.43% in 2021, then tumbled by 31.53% in 2022.
  • Adaptive Biotechnologies' Current Deferred Revenue (Yearly) stood at $73.3 million in 2020, then soared by 144.43% to $179.2 million in 2021, then crashed by 31.53% to $122.7 million in 2022, then decreased by 23.87% to $93.4 million in 2023, then decreased by 11.22% to $82.9 million in 2024.